Skip to content

The Latest Treatments for Alzheimer’s Disease

Treatment for Alzheimer's disease, the devastating condition that affects more than five million Americans, has remained notoriously elusive for decades. Now, a small study released by drug company Eli Lilly offers at least a flicker of hope: It shows that the experimental drug donanemab may significantly slow patients’ cognitive decline.
Read More
Back To Top